经皮冠脉介入治疗-话题@MedSci

#经皮冠脉介入治疗#

10篇内容 | 823人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1460453, encodeId=167e146045382, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, objectTitle=Eur Heart J：缺血性心力衰竭患者采用冠脉旁路移植术治疗的长期死亡率明显低于经皮冠脉介入治疗！, objectType=article, longId=212273, objectId=f9a52122e3bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9a52122e3bf, replyNumber=0, likeNumber=39, createdTime=2021-06-05, rootId=0, userName=zhanglin3081, userId=555a6326698, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9a52122e3bf, moduleTitle=Eur Heart J：缺血性心力衰竭患者采用冠脉旁路移植术治疗的长期死亡率明显低于经皮冠脉介入治疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9a52122e3bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460452, encodeId=e36e1460452eb, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, objectTitle=Lancet：经皮冠脉介入治疗后需无限期抗血小板治疗的患者请注意，氯吡格雷单药疗法优于阿司匹林！, objectType=article, longId=211547, objectId=899121154ea2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=899121154ea2, replyNumber=0, likeNumber=50, createdTime=2021-05-21, rootId=0, userName=zhanglin3081, userId=555a6326698, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=899121154ea2, moduleTitle=Lancet：经皮冠脉介入治疗后需无限期抗血小板治疗的患者请注意，氯吡格雷单药疗法优于阿司匹林！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=899121154ea2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460451, encodeId=78041460451fb, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, objectTitle=Circ：Cardiovasc Inte：TAVI后的冠脉通路和经皮冠脉介入治疗, objectType=article, longId=196596, objectId=cd881965961c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd881965961c, replyNumber=0, likeNumber=41, createdTime=2020-06-29, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd881965961c, moduleTitle=Circ：Cardiovasc Inte：TAVI后的冠脉通路和经皮冠脉介入治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd881965961c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460450, encodeId=16be146045079, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, objectTitle=2019 全球专家共识：慢性完全闭塞病变经皮冠脉介入治疗的指导原则, objectType=article, longId=176664, objectId=d98f1e6664ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d98f1e6664ca, replyNumber=0, likeNumber=39, createdTime=2019-08-03, rootId=0, userName=zhanglin3081, userId=555a6326698, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d98f1e6664ca, moduleTitle=2019 全球专家共识：慢性完全闭塞病变经皮冠脉介入治疗的指导原则, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d98f1e6664ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460449, encodeId=b913146044979, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, objectTitle=Circ: Cardiovasc Inte：经皮冠脉介入治疗后获得性血小板减少症的发病率、预测因子和结局, objectType=article, longId=135517, objectId=1c0113551ea6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c0113551ea6, replyNumber=0, likeNumber=47, createdTime=2018-04-18, rootId=0, userName=zhanglin3081, userId=555a6326698, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c0113551ea6, moduleTitle=Circ: Cardiovasc Inte：经皮冠脉介入治疗后获得性血小板减少症的发病率、预测因子和结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c0113551ea6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460448, encodeId=87f4146044828, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, objectTitle=Circ: Cardiovasc Inte：经皮冠脉介入治疗后的30天再入院率及费用, objectType=article, longId=124197, objectId=834912419e42, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=834912419e42, replyNumber=0, likeNumber=35, createdTime=2017-12-23, rootId=0, userName=zhanglin3081, userId=555a6326698, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=834912419e42, moduleTitle=Circ: Cardiovasc Inte：经皮冠脉介入治疗后的30天再入院率及费用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=834912419e42)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460447, encodeId=cd5f146044ed9, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, objectTitle=JACC：经同侧旁路通道的逆向慢性完全闭塞经皮冠脉介入治疗, objectType=article, longId=108853, objectId=024a108853ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=024a108853ff, replyNumber=0, likeNumber=42, createdTime=2017-08-17, rootId=0, userName=zhanglin3081, userId=555a6326698, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=024a108853ff, moduleTitle=JACC：经同侧旁路通道的逆向慢性完全闭塞经皮冠脉介入治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=024a108853ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460446, encodeId=a66c1460446eb, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, objectTitle=JACC：体质量指数与经皮冠脉介入治疗结果的关系, objectType=article, longId=104521, objectId=01ee104521ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01ee104521ac, replyNumber=0, likeNumber=44, createdTime=2017-07-06, rootId=0, userName=zhanglin3081, userId=555a6326698, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01ee104521ac, moduleTitle=JACC：体质量指数与经皮冠脉介入治疗结果的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01ee104521ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460445, encodeId=4045146044550, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, objectTitle=JACC：经皮冠脉介入治疗支架内完全闭塞的疗效观察, objectType=article, longId=98166, objectId=495b9816604, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=495b9816604, replyNumber=0, likeNumber=0, createdTime=2017-05-10, rootId=0, userName=zhanglin3081, userId=555a6326698, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=495b9816604, moduleTitle=JACC：经皮冠脉介入治疗支架内完全闭塞的疗效观察, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=495b9816604)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460444, encodeId=e86e1460444ff, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, objectTitle=经皮冠脉介入治疗中对比剂肾病的预防, objectType=article, longId=6708, objectId=970f6e08d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=970f6e08d7, replyNumber=0, likeNumber=44, createdTime=2012-05-31, rootId=0, userName=zhanglin3081, userId=555a6326698, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=970f6e08d7, moduleTitle=经皮冠脉介入治疗中对比剂肾病的预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=970f6e08d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2020-05-29

zhanglin3081 (审核中...)

前往app查看评论内容

#经皮冠脉介入治疗#

Eur Heart J：缺血性心力衰竭患者采用冠脉旁路移植术治疗的长期死亡率明显低于经皮冠脉介入治疗！

2021-06-05

zhanglin3081 (审核中...)

前往app查看评论内容

#经皮冠脉介入治疗#

Lancet：经皮冠脉介入治疗后需无限期抗血小板治疗的患者请注意，氯吡格雷单药疗法优于阿司匹林！

2021-05-21

医者仁心 (审核中...)

前往app查看评论内容

#经皮冠脉介入治疗#

Circ：Cardiovasc Inte：TAVI后的冠脉通路和经皮冠脉介入治疗

2020-06-29

zhanglin3081 (审核中...)

前往app查看评论内容

#经皮冠脉介入治疗#

2019 全球专家共识：慢性完全闭塞病变经皮冠脉介入治疗的指导原则

2019-08-03

zhanglin3081 (审核中...)

前往app查看评论内容

#经皮冠脉介入治疗#

Circ: Cardiovasc Inte：经皮冠脉介入治疗后获得性血小板减少症的发病率、预测因子和结局

2018-04-18

zhanglin3081 (审核中...)

前往app查看评论内容

#经皮冠脉介入治疗#

Circ: Cardiovasc Inte：经皮冠脉介入治疗后的30天再入院率及费用

2017-12-23

zhanglin3081 (审核中...)

前往app查看评论内容

#经皮冠脉介入治疗#

JACC：经同侧旁路通道的逆向慢性完全闭塞经皮冠脉介入治疗

2017-08-17

zhanglin3081 (审核中...)

前往app查看评论内容

#经皮冠脉介入治疗#

JACC：体质量指数与经皮冠脉介入治疗结果的关系

2017-07-06

zhanglin3081 (审核中...)

前往app查看评论内容

#经皮冠脉介入治疗#

JACC：经皮冠脉介入治疗支架内完全闭塞的疗效观察

2017-05-10

zhanglin3081 (审核中...)

前往app查看评论内容

#经皮冠脉介入治疗#

经皮冠脉介入治疗中对比剂肾病的预防

2012-05-31

科室
- - 订阅+
  - 更多科室
工具
服务